4. May 2020
imh Conference 2020 on Biosimilars
POSTPONED TO BE ON 29.-30.09.2020

On 17th and 18th March 2020, the imh would like to invite you to the pharmaceutical forum based on the biosimilar topics: market penetration / regulations / reimbursement.

Specialists from all kind of different fields will be enlightening on the latest developments in biosimilars, market dynamics and reimbursement in the European area.

They will also be commenting on the following questions:

  • Financial leeway for pharmaceutical innovations in the healthcare system: How can biosimilars help?
  • Is there an increase in acceptance of biosimilars among doctors and has it increased / will it increase the number of prescriptions?

The approval of a biosimilar product by the EMA shows that quality, safety and efficacy are comparable thus allowing a better and quicker access to quality products.

Venue: NH Danube City (Wagramer Straße 21, 1220 Wien).